Three Therapeutic Schemes for Cerebral Arteriosclerosis:Cost-Effectiveness Analysis / 中国药房
China Pharmacy
; (12)2005.
Article
em Zh
| WPRIM
| ID: wpr-530867
Biblioteca responsável:
WPRO
ABSTRACT
0.05);the costs were 459.00 yuan,481.68 yuan and 789.48 yuan,respectively,showing significant differences between Group A and Group C or between Group B and Group C(P0.05).CONCLUSION: Group A is preferable in terms of cost-effectiveness,while there was no significant difference between Group A and Group B in cost.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Health_economic_evaluation
Idioma:
Zh
Revista:
China Pharmacy
Ano de publicação:
2005
Tipo de documento:
Article